150 related articles for article (PubMed ID: 28583112)
1. Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients.
Salvaggio SE; Giacomelli A; Falvella FS; Oreni ML; Meraviglia P; Atzori C; Clementi EGI; Galli M; Rusconi S
BMC Infect Dis; 2017 Jun; 17(1):396. PubMed ID: 28583112
[TBL] [Abstract][Full Text] [Related]
2. A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection.
Likanonsakul S; Suntisuklappon B; Nitiyanontakij R; Prasithsirikul W; Nakayama EE; Shioda T; Sangsajja C
PLoS One; 2016; 11(1):e0147724. PubMed ID: 26807589
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphisms in ABCC2 associate with tenofovir-induced kidney tubular dysfunction in Japanese patients with HIV-1 infection: a pharmacogenetic study.
Nishijima T; Komatsu H; Higasa K; Takano M; Tsuchiya K; Hayashida T; Oka S; Gatanaga H
Clin Infect Dis; 2012 Dec; 55(11):1558-67. PubMed ID: 22955427
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction.
Pushpakom SP; Liptrott NJ; Rodríguez-Nóvoa S; Labarga P; Soriano V; Albalater M; Hopper-Borge E; Bonora S; Di Perri G; Back DJ; Khoo S; Pirmohamed M; Owen A
J Infect Dis; 2011 Jul; 204(1):145-53. PubMed ID: 21628669
[TBL] [Abstract][Full Text] [Related]
5. Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study.
Rodríguez-Nóvoa S; Labarga P; Soriano V; Egan D; Albalater M; Morello J; Cuenca L; González-Pardo G; Khoo S; Back D; Owen A
Clin Infect Dis; 2009 Jun; 48(11):e108-16. PubMed ID: 19400747
[TBL] [Abstract][Full Text] [Related]
6. Design and methods of the prevalence and pharmacogenomics of tenofovir nephrotoxicity in HIV-positive adults in south-western Nigeria study.
Hassan MO; Duarte R; Mabayoje VO; Dickens C; Lasisi AO; Naicker S
BMC Nephrol; 2020 Oct; 21(1):436. PubMed ID: 33066744
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment with tenofovir: prevalence of kidney tubular dysfunction and its association with tenofovir plasma concentration.
Ezinga M; Wetzels JF; Bosch ME; van der Ven AJ; Burger DM
Antivir Ther; 2014; 19(8):765-71. PubMed ID: 24584104
[TBL] [Abstract][Full Text] [Related]
8. Tenofovir-induced renal tubular dysfunction in vertically HIV-infected patients associated with polymorphisms in ABCC2, ABCC4 and ABCC10 genes.
Giacomet V; Cattaneo D; Viganò A; Nannini P; Manfredini V; Ramponi G; Clementi E; Zuccotti GV
Pediatr Infect Dis J; 2013 Oct; 32(10):e403-5. PubMed ID: 24067562
[TBL] [Abstract][Full Text] [Related]
9. Do genetic variations in proximal tubule transporters influence tenofovir-induced renal dysfunction? An exploratory study in a Ghanaian population.
Neary M; Olagunju A; Sarfo F; Phillips R; Moss D; Owen A; Chadwick D
J Antimicrob Chemother; 2020 May; 75(5):1267-1271. PubMed ID: 32060504
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients.
Cusato J; Calcagno A; Marinaro L; Avataneo V; DʹAvolio A; Di Perri G; Bonora S
Pharmacogenomics J; 2020 Apr; 20(2):202-212. PubMed ID: 31619748
[TBL] [Abstract][Full Text] [Related]
11. Cumulative exposure of TDF is associated with kidney tubulopathy whether it is currently used or discontinued.
Nishijima T; Mutoh Y; Kawasaki Y; Tomonari K; Kikuchi Y; Gatanaga H; Oka S;
AIDS; 2018 Jan; 32(2):179-188. PubMed ID: 29028660
[TBL] [Abstract][Full Text] [Related]
12. ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment.
Cheli S; Baldelli S; De Silvestri A; Fusi M; Minisci D; Gervasoni C; Cattaneo D; Clementi E; Meraviglia P; Montrasio C
Pharmacogenomics J; 2021 Oct; 21(5):586-593. PubMed ID: 33850298
[TBL] [Abstract][Full Text] [Related]
13. Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy.
Izzedine H; Hulot JS; Villard E; Goyenvalle C; Dominguez S; Ghosn J; Valantin MA; Lechat P; Deray AG
J Infect Dis; 2006 Dec; 194(11):1481-91. PubMed ID: 17083032
[TBL] [Abstract][Full Text] [Related]
14. A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome.
Dahlin A; Wittwer M; de la Cruz M; Woo JM; Bam R; Scharen-Guivel V; Flaherty J; Ray AS; Cihlar T; Gupta SK; Giacomini KM
Pharmacogenet Genomics; 2015 Feb; 25(2):82-92. PubMed ID: 25485598
[TBL] [Abstract][Full Text] [Related]
15. Drug Transporter Genetic Variants Are Not Associated with TDF-Related Renal Dysfunction in Patients with HIV-1 Infection: A Pharmacogenetic Study.
Nishijima T; Hayashida T; Kurosawa T; Tanaka N; Oka S; Gatanaga H
PLoS One; 2015; 10(11):e0141931. PubMed ID: 26535588
[TBL] [Abstract][Full Text] [Related]
16. Renal function in HIV/HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting.
Milazzo L; Gervasoni C; Falvella FS; Cattaneo D; Mazzali C; Ronzi P; Binda F; Cheli S; Sollima S; Antinori S
Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):191-196. PubMed ID: 27809359
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of tenofovir disoproxil fumarate transporters and risk of kidney tubular dysfunction in HIV-positive patients: genetics of tenofovir transporters.
Danjuma MI; Egan D; Abubeker IY; Post F; Khoo S
Int J STD AIDS; 2018 Aug; ():956462418786562. PubMed ID: 30071797
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir.
Casado JL; Bañón S; Santiuste C; Serna J; Guzman P; Tenorio M; Liaño F; del Rey JM
AIDS; 2016 Jan; 30(2):231-9. PubMed ID: 26684820
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms associated with renal adverse effects of antiretroviral therapy in a Southern Brazilian HIV cohort.
da Rocha IM; Gasparotto AS; Lazzaretti RK; Notti RK; Sprinz E; Mattevi VS
Pharmacogenet Genomics; 2015 Nov; 25(11):541-7. PubMed ID: 26287941
[TBL] [Abstract][Full Text] [Related]
20. HIV Infection, Tenofovir, and Urine α1-Microglobulin: A Cross-sectional Analysis in the Multicenter AIDS Cohort Study.
Jotwani V; Scherzer R; Estrella MM; Jacobson LP; Witt MD; Palella FJ; Macatangay B; Bennett M; Parikh CR; Ix JH; Shlipak MG
Am J Kidney Dis; 2016 Oct; 68(4):571-581. PubMed ID: 27287300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
